Journal of pediatric hematology/oncology
-
J. Pediatr. Hematol. Oncol. · May 2013
Bereaved parents and siblings offer advice to health care providers and researchers.
To determine how to improve care for families by obtaining their advice to health care providers and researchers after a child's death from cancer. ⋯ Many participants were pleased with the care the child with cancer received, but others noted areas in need of improvement, particularly medical communication and continuity of care. Additional research is needed to inform interventions to improve services for families of children with life-limiting conditions.
-
J. Pediatr. Hematol. Oncol. · May 2013
Case ReportsSuccessful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
Immune thrombocytopenic purpura (ITP) that is unresponsive to conventional treatment is uncommon. In this situation, additional therapeutic options are limited and management is challenging. We describe the case of a 10-week-old infant that developed life-threatening ITP that was unresponsive to immunoglobulin and corticosteroids that was successfully managed with the monoclonal antibody rituximab. The literature on the use of rituximab in nonresponsive ITP is reviewed.